Elevated Anti-Müllerian Hormone as a Prognostic Factor for Poor Outcomes of In Vitro Fertilization in Women with Polycystic Ovary Syndrome
Women with polycystic ovary syndrome (PCOS) tend to have elevated anti-Müllerian hormone (AMH) levels, which appear to correlate with disease severity and pregnancy outcomes. This was a retrospective observational study designed to assess the relationship between circulating AMH levels and in vitro...
Main Authors: | Emídio Vale-Fernandes, Márcia Barreiro, Carla Leal, Rosa Zulmira Macedo, António Tomé, Mariana P. Monteiro |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-11-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/11/12/3150 |
Similar Items
-
Impact of increasing antimüllerian hormone level on in vitro fertilization fresh transfer and live birth rate
by: Kelly S. Acharya, M.D., et al.
Published: (2022-09-01) -
External validation of anti-Müllerian hormone based prediction of live birth in assisted conception
by: Khader Amani, et al.
Published: (2013-01-01) -
Anti-Mullerian Hormone-Based Phenotyping Identifies Subgroups of Women with Polycystic Ovary Syndrome with Differing Clinical and Biochemical Characteristics
by: Minhthao Thi Nguyen, et al.
Published: (2023-01-01) -
Comparison of the umbilical cord Blood’s anti-Mullerian hormone level in the newborns of mothers with polycystic ovary syndrome (PCOS) and healthy mothers
by: Faezeh Tadaion Far, et al.
Published: (2019-11-01) -
The impact of the embryo banking on the cumulative live birth rate in women with poor ovarian response according to the Bologna criteria
by: Qiu Lin Ge, et al.
Published: (2023-01-01)